Trial Outcomes & Findings for Aim 1: App for Reducing Cravings to Smoke (NCT NCT06923033)

NCT ID: NCT06923033

Last Updated: 2025-11-18

Results Overview

Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale. Scores range from 0 to 100, with higher scores indicating better usability.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

14 participants

Primary outcome timeframe

At 1 week

Results posted on

2025-11-18

Participant Flow

Participant milestones

Participant milestones
Measure
Aim 1: Update an Existing Smartphone App
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction. Smartphone App: Participants will download a study app that will allow them to track smoking urges and abstinence. Access to augmented reality will become available after 48 hours of self-reported abstinence.
Overall Study
STARTED
14
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
4

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Aim 1: App for Reducing Cravings to Smoke

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Aim 1: Update an Existing Smartphone App
n=10 Participants
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction. Smartphone App: Participants will download a study app that will allow them to track smoking urges and abstinence. Access to augmented reality will become available after 48 hours of self-reported abstinence.
Age, Continuous
37.9 years
STANDARD_DEVIATION 14.2 • n=202 Participants
Sex: Female, Male
Female
4 Participants
n=202 Participants
Sex: Female, Male
Male
6 Participants
n=202 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=202 Participants
Race (NIH/OMB)
Asian
0 Participants
n=202 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=202 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=202 Participants
Race (NIH/OMB)
White
6 Participants
n=202 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=202 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=202 Participants
Region of Enrollment
United States
10 participants
n=202 Participants

PRIMARY outcome

Timeframe: At 1 week

Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale. Scores range from 0 to 100, with higher scores indicating better usability.

Outcome measures

Outcome measures
Measure
Aim 1: Update an Existing Smartphone App
n=10 Participants
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction. Smartphone App: Participants will download a study app that will allow them to track smoking urges and abstinence. Access to augmented reality will become available after 48 hours of self-reported abstinence.
System Usability Scale (Aim 1)
70.3 score on a scale
Standard Deviation 20.1

SECONDARY outcome

Timeframe: At 1 week

One Likert scale item will capture participants' satisfaction with the app. The Likert scale is from 1 to 4, with higher score indicating greater satisfaction.

Outcome measures

Outcome measures
Measure
Aim 1: Update an Existing Smartphone App
n=10 Participants
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction. Smartphone App: Participants will download a study app that will allow them to track smoking urges and abstinence. Access to augmented reality will become available after 48 hours of self-reported abstinence.
User Satisfaction (Aim 1)
3.4 score on a scale
Standard Deviation 0.6

Adverse Events

Aim 1: Update an Existing Smartphone App

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Christine Vinci, Ph.D.

Moffitt Cancer Center

Phone: 813-745-5421

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place